DBV Technologies (NASDAQ: [[ticker:DBVT]]) has appointed Pascal Wotling to serve as its chief technical operations officer. He worked most recently at Novartis (NYSE: [[ticker:NVS]]), where he was head of external supply operations for the Asia-Pacific, Middle East, and Africa. He will start at Bagneux, France-based DBV on April 1. DBV is awaiting an FDA decision for Viaskin, a skin patch developed as a peanut allergy immunotherapy.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan